Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.26.3 (
RNase III
)
1,015
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Hyper-osmotic stress strongly induces expression of the Escherichia coli proU operon encoding a high affinity uptake system for the osmoprotectants glycine
betaine
and proline
betaine
. Osmoregulation of proU takes place at the transcriptional level by upregulation of the promoter at high osmolarity and repression of transcription by the nucleoid-associated protein H-NS at low osmolarity. In the present study, we describe an additional level of proU osmoregulation that is independent of transcriptional regulation. We show that osmoregulation occurs at a post-transcriptional level involving
RNase III
.
RNase III
specifically processes the proU mRNA within a conserved secondary structure extending from position +203 to +293 of the transcript. Processing is efficient at low osmolarity, but inhibited at high osmolarity. Blocking of
RNase III
processing by mutation of the processing site eliminates post-transcriptional osmoregulation of proU. Further, the proU mRNA is relatively stable at high osmolarity with a half-life of approximately 65 sec. However, upon osmotic downshift,
RNase III
immediately processes the proU mRNA which reduces its half-life to less than 4 sec. The data suggest that the primary role of
RNase III
-mediated processing of proU mRNA is to ensure rapid shutdown of proU upon hypo-osmotic stress.
...
PMID:RNase III initiates rapid degradation of proU mRNA upon hypo-osmotic stress in Escherichia coli. 2225 44